SCHEMBL6920111

SCHEMBL6920111

Cc1nnc(-c2cccc(C(=O)N(C)[C@H](CCNC(=O)c3cccn3C)Cc3ccccc3)c2)o1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 2/20 0.68
HCRTR2 O43614 2/20 0.68
NPC1 O15118 4/20 0.42
RAB9A P51151 4/20 0.42
CTSV O60911 1/20 0.41
CTSL P07711 1/20 0.41
CTSS P25774 1/20 0.41
CTSK P43235 1/20 0.41
MAPK14 Q16539 3/20 0.40
CACNA2D1 P54289 4/20 0.38
KIFC1 Q9BW19 1/20 0.37
ALDH1A1 P00352 4/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
MAPT P10636 1/20 0.36
KDM4E B2RXH2 1/20 0.35
PADI4 Q9UM07 1/20 0.35
MAPK11 Q15759 1/20 0.35
HPGD P15428 2/20 0.35
TSHR P16473 2/20 0.35
OPRM1 P35372 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2010792 0.89 HCRTR1 (0.67) HCRTR1HCRTR2NPC1RAB9APADI4
SCHEMBL6919915 0.86 HCRTR1 (0.65) HCRTR1HCRTR2NPC1RAB9AKIFC1
SCHEMBL2013804 0.86 HCRTR1 (0.73) HCRTR1HCRTR2NPC1RAB9ACTSV
SCHEMBL2015048 0.85 HCRTR1 (0.72) HCRTR1HCRTR2NPC1RAB9ACTSL
SCHEMBL13139093 0.84 HCRTR1 (0.77) HCRTR1HCRTR2NPC1RAB9ACTSL
SCHEMBL13139060 0.83 HCRTR1 (0.77) HCRTR1HCRTR2NPC1RAB9APADI4
SCHEMBL2012115 0.83 HCRTR1 (0.65) HCRTR1HCRTR2NPC1RAB9AALDH1A1
SCHEMBL2015121 0.83 HCRTR1 (0.65) HCRTR1HCRTR2NPC1RAB9APADI4
SCHEMBL2010953 0.83 HCRTR1 (0.69) HCRTR1HCRTR2NPC1RAB9ASMN1; SMN2
SCHEMBL13139074 0.82 HCRTR1 (0.84) HCRTR1HCRTR2NPC1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011073316-A1 4-ARYL-BUTANE-1,3-DIAMIDES NOVARTIS AG (CH) 2011-06-23 WO disclosed